Endava plc
DAVA · NYSE
Market closed$2.82$0.020000 (+0.71%)After hours $2.82 · 0.00%
Key statistics
Previous close$2.80
Open$2.80
Day high$2.82
Day low$2.71
52-week high$15.20
52-week low$2.55
Market cap151.08M
Volume165.53K
Average volume385.67K
P/E ratio3.52
Forward P/E—
EPS0.80
Dividend yield0.00%
Market context
Why it moved
Endava (DAVA) edged slightly higher in extended trading, driven by modest buying interest following liquidity mapping signals around key price events, as the stock attempts to stabilize after recent fair value cuts stemming from prior guidance reductions and a Q3 earnings miss.
What is happening
Recent company-specific developments and publisher coverage.
Moomoo · July 9, 2026TD Cowen Maintains Endava(DAVA.US) With Hold Rating, Cuts Target Price to $3.5Investing.com · May 27, 2026Guggenheim downgrades Endava stock rating to neutral on weak resultsInvesting.com · May 21, 2026Earnings call transcript: Endava’s Q3 2026 EPS misses, stock drops 20%Business Wire · May 21, 2026Endava Announces Third Quarter Fiscal Year 2026 ResultsInvesting.com · May 21, 2026Endava tumbles 21% as revenue misses analyst estimates, guidance disappointsQuiver Quantitative · May 21, 2026ENDAVA ($DAVA) Releases Q3 2026 EarningsBusiness Wire · February 19, 2026Endava Announces Second Quarter Fiscal Year 2026 ResultsBusiness Wire · February 17, 2026Endava Partners with Miro to Drive Innovative New Model for AI Transformation Benzinga · July 9, 2026TD Cowen Maintains Hold on Endava, Lowers Price Target to $3.5 Mt Newswire · June 30, 2026Endava Teams Up With Wiz to Strengthen Multi-Cloud Security Mt Newswire · May 27, 2026Guggenheim Downgrades Endava to Neutral From Buy Mt Newswire · May 22, 2026Endava Shares Fall After JPMorgan Downgrade Benzinga · May 22, 2026Endava Analysts Slash Their Forecasts Following Downbeat Q3 Results Benzinga · May 22, 2026Morgan Stanley Maintains Equal-Weight on Endava, Lowers Price Target to $4 Benzinga · May 22, 2026JP Morgan Downgrades Endava to Underweight, Lowers Price Target to $5 Mt Newswire · May 22, 2026JPMorgan Downgrades Endava to Underweight From Neutral, Adjusts Price Target to $5 From $9